Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 ...

The healthcare industry experienced a rollercoaster of a year in 2024, with pharmacy benefits undergoing significant shifts.

The new business venture of Spotify founder Daniel Ek – Neko Health – has raised $260 million to bring its full body-scanning ...

AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as ...

SIFI, an Italian ophthalmology company focused mostly on the European market, doesn’t normally make it out to San Francisco ...

The story of HCPs’ advocacy for the Treat and Reduce Obesity Act reveals a broader truth: HCPs care deeply about the ...

In fact, a McKinsey study found that “while 90% of companies have launched some flavour of digital transformation, only a ...

The Tony Blair Institute for Global Change, recently estimated that AI could significantly impact the UK job market, ...

US health insurance giant UnitedHealth Group has appointed company veteran Tim Noel as chief executive of UnitedHealthcare, ...

Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of ...

Take a look at three predictions for the year ahead for pharma executives considering AI implementation and adoption. For AI ...

Spinraza remains a big product for Biogen, but has seen its sales go into reverse as competition in SMA treatment has emerged ...